Artwork
iconShare
 
Manage episode 498523781 series 2970140
Content provided by Mr. D.J. Ferguson, MS, BCMAS, PharmD Candidate, RSci MRSB MRSC, Mr. D.J. Ferguson, MS, BCMAS, PharmD Candidate, and RSci MRSB MRSC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mr. D.J. Ferguson, MS, BCMAS, PharmD Candidate, RSci MRSB MRSC, Mr. D.J. Ferguson, MS, BCMAS, PharmD Candidate, and RSci MRSB MRSC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

The Making of KOLs: The New Chemist Podcast’s Global Journey in Science, Pharma, and Education: Interview with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai

---In this episode , we sit down with Mohan Uttarwar, CEO & Co-Founder of 1Cell.Ai, to explore how AI-driven single-cell analytics are revolutionizing precision oncology. Discover how the OncoIncytes platform merges ctDNA, live CTCs, single-cell RNA and proteomics for a real-time, multimodal tumor profile—and learn how these insights are sharpening patient selection, accelerating ADC trials, and delivering earlier, more accurate measures of therapeutic response. Mohan also shares his playbook for building a capital-efficient biotech across Silicon Valley and India, the emerging trends set to reshape drug development, and practical advice for chemists, data scientists, and founders looking to break into the field. Tune in this August for a deep dive into the future of cancer research and drug discovery.--

Please note: The views of this podcast represent those of my guest(s) and I.

Music citation: Open source

  continue reading

322 episodes